We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.

Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
Stats
0.00%
Supply change
0.00 USDC
Liquidity
—
Mayhem trades
-0 USDC
Mayhem Agent Profit
Actions
Mayhem agent completed
Mayhem mode has ended, either the 24-hour window expired or the SOL reserves were depleted.
In a phase III trial involving more than 1,100 high-risk or advanced melanoma patients, a key objective was met: significantly extending the time patients remained melanoma-free compared to Keytruda alone. The treatment also reduced the risk of the cancer spreading to other parts of the body. These results build on positive phase II trial data for the same regimen earlier this year.